NextCure, Inc. announced that it has received $67 million in funding from a group of investors.

On January 6, 2016, NextCure, Inc. closed the transaction. The company has received series A round of funding. The transaction included participation from seven investors including new investors, Canaan Partners, Lilly Asia Ventures, OrbiMed Advisors, L.L.C., Pfizer Inc., new investor Sofinnova Ventures, Inc., and Alexandria Venture Investments.